Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Dendreon Corporation    DNDN   US24823Q1076

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 
Latest news on DENDREON CORPORATION
1d ago DENDREON : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K..
11/12 DENDREON : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or..
11/11 DENDREON : Seattle's Dendreon files for Ch. 11 bankruptcy protection
11/11 DENDREON : Chapter 11 Filing story (Clarification)
11/11 DENDREON CORPORATION : Bankruptcies, Breakouts, and Busts; What's Happening in B..
11/10DJMARKET SNAPSHOT : U.S. Stocks Eke Out Monday Gains; S&P 500, Dow Hit Records
11/10DJMARKET SNAPSHOT : U.S. Stocks Eke Out Monday Gains; S&P 500, Dow Hit Records
11/10DJMARKET SNAPSHOT : U.S. Stocks Eke Out Monday Gains; S&P 500, Dow Hit Records
11/10DJMARKET SNAPSHOT : U.S. Stocks Eke Out Monday Gains; S&P 500, Dow Hit Records
11/10DJMARKET SNAPSHOT : U.S. Stocks Eke Out Monday Gains; S&P 500, Dow Hit Records
11/10DJMARKET SNAPSHOT : S&P 500, Dow Hit Intraday Record Highs
11/10DJMARKET SNAPSHOT : U.S. Stocks: S&P 500's Record Highs May Be Put To The Test
11/10 DENDREON : Drugmaker Dendreon files for Chapter 11 bankruptcy reorganization
11/10 DENDREON : files for Ch. 11 bankruptcy protection
11/10 DENDREON : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
11/10 DENDREON : Entry into a Material Definitive Agreement, Bankruptcy or Receivershi..
11/10 DENDREON : Reaches Agreements on Terms of Financial Restructuring
09/12 Feature - As music sales fall, sax player Kenny G turns to stockpicking
08/12 DENDREON : sinks after drugmaker warns of debt woes
08/11 DENDREON : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
08/06 Dendreon Names W. Thomas Amick President and Chief Executive Officer
08/06 DENDREON : Elects W. Thomas Amick as President and CEO
08/04 DENDREON : Taps W. Thomas Amick President
07/31 DENDREON : Names W. Thomas Amick President and Chief Executive Officer
07/30 DENDREON : Change in Directors or Principal Officers, Financial Statements and E..
07/30 DENDREON : Names W. Thomas Amick President and Chief Executive Officer
06/18 DENDREON : Termination of a Material Definitive Agreement (form 8-K)
06/09 DENDREON : Change in Directors or Principal Officers, Financial Statements and E..
06/09 DENDREON : Announces Leadership Transition
05/28 DENDREON : Treatment with PROVENGE® sipuleucel-T Induces Antigen Spread Associat..
05/21 DENDREON : Submission of Matters to a Vote of Security Holders (form 8-K)
05/21 DENDREON : Announces Presentation of PROVENGE® sipuleucel-T and DN24-02 Immuno-O..
05/20 DENDREON : Treatment with PROVENGE® (sipuleucel-T) Induces Antigen Spread Associ..
05/20 DENDREON : to Present Provenge (sipuleucel-T) and DN24-02 Immuno- Oncology Data ..
05/15 DENDREON : Announces First Quarter 2014 Results
05/14 DENDREON : Announces Presentation of PROVENGE® (sipuleucel-T) and DN24-02 Immuno..
05/08 DENDREON : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
05/08 DENDREON : Results of Operations and Financial Condition, Financial Statements a..
05/08 DENDREON : Announces First Quarter 2014 Results
05/05DENDREON CORPORATION : quaterly earnings release
04/28 DENDREON : to Host Conference Call on May 8 to Announce First Quarter Financial ..
04/25 DENDREON : Posts Preliminary Data from Analysis of Phase II Stand Study
04/23 DENDREON : Immune Responses Enhanced and Sustained When PROVENGE® sipuleucel-T i..
04/17 DENDREON : Releases Preliminary Data from Analysis of Phase II Stand Study
04/11 DENDREON : Immune Responses Enhanced and Sustained When PROVENGE® (sipuleucel-T)..
03/12 DENDREON : Announces Fourth Quarter and 2013 Year End Results
03/12 DENDREON : Announces Plans to Make PROVENGE® Commercially Available in Europe
03/10 Exclusive - Germany OKs Northwest Bio brain cancer drug, shares soar
03/07 DENDREON CORPORATION : DENDREON CORP FILES (8-K) Disclosing Change in Directors ..
03/06 DENDREON CORPORATION : Dendreon Reports Intent to Make Provenge Commercially Ava..
03/05 DENDREON CORPORATION : Patent Issued for Promiscuous HER-2/Neu CD4 T Cell Epitop..
03/04 DENDREON CORPORATION : Dendreon Corp. Assigned Patent
03/03 DENDREON CORPORATION : Dendreon Tests Resistance on Earnings Report, Provenge Ex..
03/03DJU.S. HOT STOCKS : Hot Stocks to Watch
03/03 Dendreon shares jump on news of prostate drug's European launch
03/03 DENDREON CORPORATION : Dendreon Announces Plans to Make PROVENGE® Commercially A..
03/03 DENDREON CORPORATION : DENDREON CORP FILES (8-K) Disclosing Results of Operation..
03/03 DENDREON CORPORATION : Dendreon Announces Plans to Make PROVENGE® Commercially A..
03/03 DENDREON CORPORATION : Dendreon Announces Fourth Quarter and 2013 Year End Resul..
02/26 DENDREON CORPORATION : Dendreon Announces Webcast Presentation at Cowen and Comp..
02/25 DENDREON CORPORATION : SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP ..
02/20 DENDREON CORPORATION : Dendreon Announces Webcast Presentation at Cowen and Comp..
02/19 DENDREON CORPORATION : Patent Issued for Promiscuous PAP CD4 T Cell Epitopes
02/17 DENDREON CORPORATION : Dendreon Assigned Paten
02/14 DENDREON CORPORATION : Dendreon to Host Conference Call on March 3 to Announce F..
02/09 DENDREON CORPORATION : Dendreon Presents Provenge Data at Genitourinary Cancer S..
02/06 DENDREON CORPORATION : DENDREON CORP FILES (8-K) Disclosing Change in Directors ..
02/04 DENDREON CORPORATION : Dendreon Presents Provenge Data at Genitourinary Cancer S..
01/30 DENDREON CORPORATION : Dendreon Announces Presentation of PROVENGE® (sipuleucel-..
01/30 DENDREON CORPORATION : Dendreon Announces Presentation of PROVENGE® (sipuleucel-..
01/22 DENDREON CORPORATION : Dendreon Announces Preliminary Fourth Quarter 2013 Revenu..
01/14 DENDREON CORPORATION : Dendreon Releases Change to Presentation Date and Time at..
01/13 DENDREON CORPORATION : Dendreon spikes on strong 4Q revenue report
01/13 DENDREON CORPORATION : Dendreon spikes on strong 4Q revenue report
01/13 DENDREON CORPORATION : DENDREON CORP FILES (8-K) Disclosing Change in Directors ..
1  2  3  4Next
Advertisement
Chart
Duration : Period :
Dendreon Corporation Technical Analysis Chart | DNDN | US24823Q1076 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF